Skip to main content
SpringerLink
Log in

In vitro antimicrobial activity of moxifloxacin against bacterial strains isolated from blood of neutropenic cancer patients

  • Brief Report
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kern WV, Cometta A, de Bock R, Langenaeken J, Paesmans M, Gaya H, for the International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer (1999) Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. N Engl J Med 341:312–318

    Article  PubMed  CAS  Google Scholar 

  2. Freifeld A, Marchigiani D, Walsh T, Chanock S, Lewis L, Hiemenz J, Hiemenz S, Hicks JE, Gill V, Steinberg SM, Pizzo PA (1999) A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med 341:305–311

    Article  PubMed  CAS  Google Scholar 

  3. Cometta A, Calandra T, Bille J, Glauser MP (1994) Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia. N Engl J Med 330:1240–1241

    Article  PubMed  CAS  Google Scholar 

  4. Keating GM, Scott LJ (2004) Moxifloxacin: a review of its use in the management of bacterial infections. Drugs 64:2347–2377

    Article  PubMed  CAS  Google Scholar 

  5. Cometta A, Calandra T, Gaya H, Zinner SH, de Bock R, Del Favero A, Bucaneve G, Crokaert F, Kern WV, Klastersky J, Langenaeken J, Micozzi A, Padmos A, Paesmans M, Viscoli C, Glauser MP, for The EORTC International Antimicrobial Therapy Cooperative Group (1996) Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemother 40:1108–1115

    PubMed  CAS  Google Scholar 

  6. Cometta A, Kern WV, de Bock R, Paesmans M, Vandenbergh M, Crokaert F, Engelhard D, Marchetti O, Akan H, Skoutelis A, Korten V, Vandercam B, Gaya H, Padmos A, Klastersky J, Zinner SH, Glauser M, Calandra T, Viscoli C, for the International Antimicrobial Therapy Group of the European Organization for Research and Treatment of Cancer (2003) Vancomycin versus placebo for persistent fever in neutropenic cancer patients given piperacillin/tazobactam monotherapy: an EORTC-IATG multicenter, double-blind, placebo-controlled trial. Clin Infect Dis 37:382–389

    Article  PubMed  CAS  Google Scholar 

  7. Murray PQ (2003) Manual of clinical microbiology. 8th edition. ASM, Washington DC. pp 185–207

    Google Scholar 

  8. Clinical and Laboratory Standards Institute (CLSI) (2005) Performance standards for antimicrobial susceptibility testing. Fifteenth informational supplement. CLSI document, vol 25(1):M100–S15

  9. Soussy CJ, Nguyen J, Goldstein F, Dabernat H, Andremont A, Leclercq R, Drugeon H, Cavallo P, Chardon H, Etienne J, Rio Y, Courvalin P (2003) In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study. Clin Microbiol Infect 9:997–1005

    Article  PubMed  CAS  Google Scholar 

  10. Rolston KV, Frisbee-Hume S, LeBlanc B, Streeter H, Ho DH (2003) In vitro antimicrobial activity of moxifloxacin compared to other quinolones against recent clinical bacterial isolates from hospitalized and community-based cancer patients. Diagn Microbiol Infect Dis 47:441–449

    Article  PubMed  CAS  Google Scholar 

  11. Ramphal R (2004) Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis 39 (Suppl 1):25–31

    Article  Google Scholar 

Download references

Acknowledgements

This work has been supported by a research grant from Bayer Vital GmBH, Leverkusen, Germany. We thank Mrs. M. Giddey and Dr. J.D. Baumgartner for their technical assistance.

Author information

Authors and Affiliations

  1. Infectious Diseases Service, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, 1011, Lausanne, Switzerland

    A. Cometta, O. Marchetti & T. Calandra

  2. Institute of Clinical Microbiology, Centre Hospitalier Universitaire Vaudois, 1011, Lausanne, Switzerland

    J. Bille

  3. Center for Infectious Diseases and Travel Medicine, Department of Medicine, University Hospital, 79106, Freiburg, Germany

    W. V. Kern

  4. Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge and Boston, MA, USA

    S. Zinner

Authors
  1. A. Cometta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. Marchetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Calandra
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Bille
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. W. V. Kern
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Zinner
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (EORTC-IDG)

Corresponding author

Correspondence to A. Cometta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cometta, A., Marchetti, O., Calandra, T. et al. In vitro antimicrobial activity of moxifloxacin against bacterial strains isolated from blood of neutropenic cancer patients. Eur J Clin Microbiol Infect Dis 25, 537–540 (2006). https://doi.org/10.1007/s10096-006-0175-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-006-0175-2

Keywords

Search

Navigation